Literature DB >> 31361966

Protein tyrosine phosphatase 11 acts through RhoA/ROCK to regulate eosinophil accumulation in the allergic airway.

Chengyun Xu1, Xiling Wu2, Meiping Lu2, Lanfang Tang2, Hongyi Yao3, Jirong Wang1, Xing Ji1, Musaddique Hussain1, Junsong Wu4, Ximei Wu1.   

Abstract

Src homology domain 2-containing protein tyrosine phosphatase 2 (SHP2) participates in multiple cell functions including cell shape, movement, and differentiation. Therefore, we investigated the potential role of SHP2 in eosinophil recruitment into lungs in allergic airway inflammation and explored the underlying mechanism. Both SHP2 and Ras homolog family member A (RhoA) kinase were robustly activated in the airway eosinophils of children with allergic asthma and of a mouse model with allergic airway inflammation. Moreover, inhibition of SHP2 activity by its specific inhibitors reverses the dephosphorylation of p190-A Rho GTPase-activating protein and in turn attenuates RhoA/Rho-associated protein kinase (ROCK) signaling, resulting in the attenuation of eosinophil migration in response to platelet-activating factor stimulation. Specifically, SHP2 deletion in myeloid cells did not affect the number and classification of circulating leukocytes but significantly attenuated the allergen-induced inflammatory cell, especially eosinophil, infiltration into lungs, and airway hyperreactivity. Notably, genetic interaction between RhoA and SHP2 indicated that RhoA inactivation and SHP2 deletion synergistically attenuated the allergen-induced eosinophil infiltration into lungs and airway hyperreactivity, whereas overexpression of active RhoA robustly restored the SHP2 deletion-resultant attenuation of allergen-induced eosinophil recruitment into lungs and airway hyperreactivity as well. Thus, this study demonstrates that SHP2 via RhoA/ROCK signaling regulates eosinophil recruitment in allergic airway inflammation and possibly in allergic asthma.-Xu, C., Wu, X., Lu, M., Tang, L., Yao, H., Wang, J., Ji, X., Hussain, M., Wu, J., Wu, X. Protein tyrosine phosphatase 11 acts through RhoA/ROCK to regulate eosinophil accumulation in the allergic airway.

Entities:  

Keywords:  SHP2; airway inflammation; asthma; cell migration

Mesh:

Substances:

Year:  2019        PMID: 31361966      PMCID: PMC6902720          DOI: 10.1096/fj.201900698R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  40 in total

1.  Loss of Shp2 in alveoli epithelia induces deregulated surfactant homeostasis, resulting in spontaneous pulmonary fibrosis.

Authors:  Xue Zhang; Yun Zhang; Bo Tao; Li Teng; Yanwei Li; Rui Cao; Qiu Gui; Madong Ye; Xiaozhou Mou; Hongqiang Cheng; Hu Hu; Ren Zhou; Ximei Wu; Qiangmin Xie; Wen Ning; Maode Lai; Huahao Shen; Gen-Sheng Feng; Yuehai Ke
Journal:  FASEB J       Date:  2012-02-23       Impact factor: 5.191

Review 2.  Wnt/β-catenin signaling links embryonic lung development and asthmatic airway remodeling.

Authors:  Musaddique Hussain; Chengyun Xu; Meiping Lu; Xiling Wu; Lanfang Tang; Ximei Wu
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-09-01       Impact factor: 5.187

3.  Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study.

Authors:  Mario Castro; Sameer Mathur; Frederick Hargreave; Louis-Philippe Boulet; Fang Xie; James Young; H Jeffrey Wilkins; Timothy Henkel; Parameswaran Nair
Journal:  Am J Respir Crit Care Med       Date:  2011-08-18       Impact factor: 21.405

4.  RhoA signaling through platelet P2Y₁ receptor controls leukocyte recruitment in allergic mice.

Authors:  Richard T Amison; Stefania Momi; Abigail Morris; Giorgia Manni; Sandra Keir; Paolo Gresele; Clive P Page; Simon C Pitchford
Journal:  J Allergy Clin Immunol       Date:  2014-10-31       Impact factor: 10.793

Review 5.  New Anti-Eosinophil Drugs for Asthma and COPD: Targeting the Trait!

Authors:  Elisabeth H Bel; Anneke Ten Brinke
Journal:  Chest       Date:  2017-06-02       Impact factor: 9.410

6.  Development of an efficient "substrate-trapping" mutant of Src homology phosphotyrosine phosphatase 2 and identification of the epidermal growth factor receptor, Gab1, and three other proteins as target substrates.

Authors:  Yehenew M Agazie; Michael J Hayman
Journal:  J Biol Chem       Date:  2003-02-11       Impact factor: 5.157

7.  Roles of Bcl-2 and caspase-9 and -3 in CD30-induced human eosinophil apoptosis.

Authors:  Hye Jin Lee; Eun-Kyoung Lee; Young Eun Seo; Youn Ho Shin; Hwan Soo Kim; Yoon Hong Chun; Jong-Seo Yoon; Hyun Hee Kim; Man Yong Han; Chang-Keun Kim; Kyu-Earn Kim; Young Yull Koh; Jin Tack Kim
Journal:  J Microbiol Immunol Infect       Date:  2015-06-30       Impact factor: 4.399

8.  Angiotensin II induces RhoA activation through SHP2-dependent dephosphorylation of the RhoGAP p190A in vascular smooth muscle cells.

Authors:  Jeremy Bregeon; Gervaise Loirand; Pierre Pacaud; Malvyne Rolli-Derkinderen
Journal:  Am J Physiol Cell Physiol       Date:  2009-08-19       Impact factor: 4.249

9.  Cross-talk between ICAM-1 and granulocyte-macrophage colony-stimulating factor receptor signaling modulates eosinophil survival and activation.

Authors:  Konrad Pazdrak; Travis W Young; Susan Stafford; Barbara Olszewska-Pazdrak; Christof Straub; Vitaliy Starosta; Allan Brasier; Alexander Kurosky
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

10.  Eosinophil differentiation in the bone marrow is promoted by protein tyrosine phosphatase SHP2.

Authors:  L-x Xia; W Hua; Y Jin; B-p Tian; Z-w Qiu; C Zhang; L-q Che; H-b Zhou; Y-f Wu; H-q Huang; F Lan; Y-h Ke; J J Lee; W Li; S-m Ying; Z-h Chen; H-h Shen
Journal:  Cell Death Dis       Date:  2016-04-07       Impact factor: 8.469

View more
  10 in total

Review 1.  Modulation of IL-4/IL-13 cytokine signaling in the context of allergic disease.

Authors:  Archana Shankar; Jaclyn W McAlees; Ian P Lewkowich
Journal:  J Allergy Clin Immunol       Date:  2022-08       Impact factor: 14.290

2.  Dissecting protein tyrosine phosphatase signaling by engineered chemogenetic control of its activity.

Authors:  Jordan Fauser; Vincent Huyot; Jacob Matsche; Barbara N Szynal; Yuri Alexeev; Pradeep Kota; Andrei V Karginov
Journal:  J Cell Biol       Date:  2022-07-13       Impact factor: 8.077

Review 3.  A comprehensive review of SHP2 and its role in cancer.

Authors:  Moges Dessale Asmamaw; Xiao-Jing Shi; Li-Rong Zhang; Hong-Min Liu
Journal:  Cell Oncol (Dordr)       Date:  2022-09-06       Impact factor: 7.051

Review 4.  Targeting protein phosphatases for the treatment of inflammation-related diseases: From signaling to therapy.

Authors:  Jie Pan; Lisha Zhou; Chenyang Zhang; Qiang Xu; Yang Sun
Journal:  Signal Transduct Target Ther       Date:  2022-06-04

5.  Nasal DNA methylation differentiates severe from non-severe asthma in African-American children.

Authors:  Tao Zhu; Xue Zhang; Xiaoting Chen; Anthony P Brown; Matthew T Weirauch; Theresa W Guilbert; Gurjit K Khurana Hershey; Jocelyn M Biagini; Hong Ji
Journal:  Allergy       Date:  2020-11-25       Impact factor: 13.146

Review 6.  RhoA/Rho-kinases in asthma: from pathogenesis to therapeutic targets.

Authors:  Yan Zhang; Arjun Saradna; Rhea Ratan; Xia Ke; Wei Tu; Danh C Do; Chengping Hu; Peisong Gao
Journal:  Clin Transl Immunology       Date:  2020-04-29

7.  RhoA/Rock activation represents a new mechanism for inactivating Wnt/β-catenin signaling in the aging-associated bone loss.

Authors:  Wei Shi; Chengyun Xu; Ying Gong; Jirong Wang; Qianlei Ren; Ziyi Yan; Liu Mei; Chao Tang; Xing Ji; Xinhua Hu; Meiyu Qv; Musaddique Hussain; Ling-Hui Zeng; Ximei Wu
Journal:  Cell Regen       Date:  2021-03-03

8.  Suppression of VEGFD expression by S-nitrosylation promotes the development of lung adenocarcinoma.

Authors:  Qiangqiang He; Meiyu Qu; Tingyu Shen; Yana Xu; Jiahao Luo; Dan Tan; Chengyun Xu; Muhammad Qasim Barkat; Ling-Hui Zeng; Ximei Wu
Journal:  J Exp Clin Cancer Res       Date:  2022-08-08

9.  Dexmedetomidine Attenuates Neurotoxicity in Developing Rats Induced by Sevoflurane through Upregulating BDNF-TrkB-CREB and Downregulating ProBDNF-P75NRT-RhoA Signaling Pathway.

Authors:  Yunxia Dong; Wei Hong; Zhiyin Tang; Yan Gao; Xiuying Wu; Hongtao Liu
Journal:  Mediators Inflamm       Date:  2020-06-20       Impact factor: 4.711

10.  Type II alveolar epithelial cell-specific loss of RhoA exacerbates allergic airway inflammation through SLC26A4.

Authors:  Danh C Do; Yan Zhang; Wei Tu; Xinyue Hu; Xiaojun Xiao; Jingsi Chen; Haiping Hao; Zhigang Liu; Jing Li; Shau-Ku Huang; Mei Wan; Peisong Gao
Journal:  JCI Insight       Date:  2021-07-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.